Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511
Transl Oncol. 2023 Jan:27:101574.
doi: 10.1016/j.tranon.2022.101574.
Epub 2022 Nov 3.
1 St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
2 St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
3 St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India.
4 Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
5 MOSC Medical College, Kolenchery, Kerala, India.
6 Sri Shankara Cancer Hospital and Research Centre, Bangalore, India.
7 Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
8 Clinical Trials and Statistical Unit, The Institute of Cancer Research, London, UK.
9 Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Electronic address: Anguraj.sadanandam@icr.ac.uk.